Literature DB >> 21950502

British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011.

S J Meggitt1, A V Anstey, M F Mohd Mustapa, N J Reynolds, S Wakelin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21950502     DOI: 10.1111/j.1365-2133.2011.10575.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  27 in total

Review 1.  Systemic treatment of adult atopic dermatitis.

Authors:  Hannah Cookson; Catherine Smith
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

Review 2.  Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2014-02-04       Impact factor: 3.869

Review 3.  Current concepts in the diagnosis and management of autoimmune hepatitis.

Authors:  Stephen Kriese; Michael A Heneghan
Journal:  Frontline Gastroenterol       Date:  2012-11-12

4.  Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring.

Authors:  Maura Caufield; Wynnis L Tom
Journal:  J Am Acad Dermatol       Date:  2012-08-11       Impact factor: 11.527

Review 5.  Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.

Authors:  Henry M Dunnenberger; Kristine R Crews; James M Hoffman; Kelly E Caudle; Ulrich Broeckel; Scott C Howard; Robert J Hunkler; Teri E Klein; William E Evans; Mary V Relling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-02       Impact factor: 13.820

6.  Clinical predictors of thiopurine-related adverse events in Crohn's disease.

Authors:  Gordon W Moran; Marie-France Dubeau; Gilaad G Kaplan; Hong Yang; Bertus Eksteen; Subrata Ghosh; Remo Panaccione
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 7.  Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses.

Authors:  J M Campbell; M D Stephenson; E Bateman; M D J Peters; D M Keefe; J M Bowen
Journal:  Pharmacogenomics J       Date:  2016-08-09       Impact factor: 3.550

8.  Implementation of TPMT testing.

Authors:  Lynne Lennard
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

9.  Checklists for safe prescribing in oral medicine clinics.

Authors:  M K Shephard; C Venda Nova; P Thakrar; T Hodgson
Journal:  Br Dent J       Date:  2017-10-27       Impact factor: 1.626

Review 10.  Pharmacogenetics and interstitial lung disease.

Authors:  Justin M Oldham; Imre Noth; Fernando J Martinez
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.